Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis
Clinical trial NCT04480086 · TERMINATED
Trial details
- NCT number
- NCT04480086
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2023-07-28
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.